Pages that link to "Q52002583"
Jump to navigation
Jump to search
The following pages link to Expressional and epigenetic alterations of placental serine protease inhibitors: SERPINA3 is a potential marker of preeclampsia (Q52002583):
Displaying 50 items.
- The placenta: phenotypic and epigenetic modifications induced by Assisted Reproductive Technologies throughout pregnancy (Q26795427) (← links)
- Regulation of TIMP-1 in Human Placenta and Fetal Membranes by lipopolysaccharide and demethylating agent 5-aza-2'-deoxycytidine (Q28397099) (← links)
- The intensity of IUGR-induced transcriptome deregulations is inversely correlated with the onset of organ function in a rat model (Q28743318) (← links)
- Differential gene expression profiling in HELLP syndrome placentas. (Q33329061) (← links)
- DNA methylation is altered in maternal blood vessels of women with preeclampsia (Q33714783) (← links)
- Differential methylation of genes associated with cell adhesion in preeclamptic placentas. (Q33806626) (← links)
- Expression of the SERPING1 gene is not regulated by promoter hypermethylation in peripheral blood mononuclear cells from patients with hereditary angioedema due to C1-inhibitor deficiency. (Q33969976) (← links)
- Genome-wide hypermethylation coupled with promoter hypomethylation in the chorioamniotic membranes of early onset pre-eclampsia (Q34040496) (← links)
- DNA methylation profiling of human placentas reveals promoter hypomethylation of multiple genes in early-onset preeclampsia (Q34329498) (← links)
- Trophoblasts, invasion, and microRNA. (Q34390117) (← links)
- Role of nitric oxide in placental vascular development and function (Q35555933) (← links)
- Epigenetics and microRNAs in preeclampsia (Q36103371) (← links)
- Regulation of MT1-MMP/MMP-2/TIMP-2 axis in human placenta (Q36140125) (← links)
- Association between Interleukin-10 gene polymorphisms and risk of early-onset preeclampsia (Q36262001) (← links)
- DNA methylation in the human placenta and fetal growth (review). (Q36383223) (← links)
- Up-regulated expression and aberrant DNA methylation of LEP and SH3PXD2A in pre-eclampsia (Q36721304) (← links)
- The role of redox signaling in epigenetics and cardiovascular disease (Q36761147) (← links)
- Genes and the preeclampsia syndrome (Q37053831) (← links)
- Pathogenesis and promising non-invasive markers for preeclampsia (Q37199922) (← links)
- Immune system disturbances in schizophrenia. (Q37344544) (← links)
- miR-34a expression, epigenetic regulation, and function in human placental diseases (Q37591525) (← links)
- Transcriptome remodeling in hypoxic inflammation (Q37720331) (← links)
- Epigenetics and the placenta (Q37801493) (← links)
- Epigenetics and hypertension (Q37815049) (← links)
- Dynamic proteome in enigmatic preeclampsia: an account of molecular mechanisms and biomarker discovery (Q37996960) (← links)
- Prediction of preeclampsia-bench to bedside (Q38252740) (← links)
- Oxidative stress and DNA methylation regulation in the metabolic syndrome (Q38459861) (← links)
- Gene expression profile analysis for different idiopathic interstitial pneumonias subtypes (Q38474468) (← links)
- Potential role of folate in pre-eclampsia (Q38584627) (← links)
- Prenatal Growth Patterns and Birthweight Are Associated With Differential DNA Methylation and Gene Expression of Cardiometabolic Risk Genes in Human Placentas: A Discovery-Based Approach. (Q38685953) (← links)
- Hypermethylation of the HLA-G promoter is associated with preeclampsia (Q38859599) (← links)
- Genetic, metabolic and endocrine aspect of intrauterine growth restriction: an update (Q38975741) (← links)
- Genetic and epigenetic mechanisms collaborate to control SERPINA3 expression and its association with placental diseases (Q39412031) (← links)
- Identification of DNA methylation markers for lineage commitment of in vitro hepatogenesis (Q39556135) (← links)
- Prevention of gravidic endothelial hypertension by aspirin treatment administered from the 8th week of gestation (Q39712096) (← links)
- DNA Methylation Profiles of Protease Nexin 1 (SERPINE2) Gene in Human Cell Lines (Q41638376) (← links)
- Promoter hypomethylation of COMT in human placenta is not associated with the development of pre-eclampsia (Q43530640) (← links)
- Preeclampsia-associated stresses activate Gadd45a signaling and sFlt-1 in placental explants (Q43744904) (← links)
- Promoter hypomethylation of TIMP3 is associated with pre-eclampsia in a Chinese population (Q44037768) (← links)
- Detection of global DNA methylation and paternally imprinted H19 gene methylation in preeclamptic placentas. (Q46163849) (← links)
- DNA Methylation and Expression Patterns of Selected Genes in First-Trimester Placental Tissue from Pregnancies with Small-for-Gestational-Age Infants at Birth. (Q53220894) (← links)
- Marinobufagenin is an upstream modulator of Gadd45a stress signaling in preeclampsia (Q53300122) (← links)
- Expressional and epigenetic alterations of placental matrix metalloproteinase 9 in preeclampsia. (Q54466912) (← links)
- Analysis of the Epigenome in Multiplex Pre-eclampsia Families Identifies , , and as Novel Candidate Risk Genes (Q64075036) (← links)
- Epigenetic Mechanisms and Hypertension (Q90667057) (← links)
- Optimal Function Prediction of Key Aberrant Genes in Early-onset Preeclampsia Using a Modified Network-based Guilt by Association Method (Q90731443) (← links)
- Epigenetic modification: a regulatory mechanism in essential hypertension (Q92341954) (← links)
- Modulation of Placental Gene Expression in Small-for-Gestational-Age Infants (Q92637252) (← links)
- Hypertensive Disorders of Pregnancy and DNA Methylation in Newborns (Q92966139) (← links)
- Molecular Targets of Aspirin and Prevention of Preeclampsia and Their Potential Association with Circulating Extracellular Vesicles during Pregnancy (Q93156154) (← links)